The production of chemical and pharmaceutical products in the UK exhibited significant fluctuations over the past decade. From 2013 to 2019, there was a mix of minimal growth and slight declines, followed by a sharp drop in 2020 attributed to disruptions caused by the COVID-19 pandemic. However, a substantial recovery was observed in 2021 with a year-on-year increase of 34.42%. This rebound was followed by a decline in 2022 and a modest recovery in 2023, standing at 65.88 billion pounds sterling. The compound annual growth rate (CAGR) over the last five years varied, showing a recent average annual increase of 1.16% up to 2023.
Forward-looking projections indicate a positive trend with a forecasted CAGR of 1.02% from 2024 to 2028, suggesting continued but modest growth in production. By 2028, production is expected to reach approximately 70.77 billion pounds sterling, reflecting a 5.19% increase from the 2023 levels.
Future trends to watch for include:
- Potential impacts of post-Brexit regulations on the chemical and pharmaceutical industries.
- Advancements in biopharmaceuticals and specialty chemicals driving sectoral growth.
- Global supply chain adjustments and their effect on production volume and value.
- Long-term implications of sustainability practices and green chemistry innovations.
